Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 39

    1.

    Viral hepatitis in the elderly.

    Carrion AF, Martin P.

    Am J Gastroenterol. 2012 May;107(5):691-7. doi: 10.1038/ajg.2012.7. Epub 2012 Jan 31.

    PMID:
    22290404
    [PubMed - in process]
    2.

    Editorial: staging liver fibrosis in hepatitis C: a challenge for this decade.

    Lai M, Afdhal NH.

    Am J Gastroenterol. 2011 Dec;106(12):2121-2. doi: 10.1038/ajg.2011.343.

    PMID:
    22138940
    [PubMed - indexed for MEDLINE]
    3.

    Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.

    Rizzo L, Calvaruso V, Cacopardo B, Alessi N, Attanasio M, Petta S, Fatuzzo F, Montineri A, Mazzola A, L'abbate L, Nunnari G, Bronte F, Di Marco V, Craxì A, Cammà C.

    Am J Gastroenterol. 2011 Dec;106(12):2112-20. doi: 10.1038/ajg.2011.341. Epub 2011 Oct 4.

    PMID:
    21971536
    [PubMed - indexed for MEDLINE]
    4.

    Could trastuzumab suppress hepatitis C virus in a patient with chronic hepatitis and breast cancer?

    Tamori A, Kawajiri H, Takashima T, Motoyama H, Morikawa H, Enomoto M, Hirakawa K, Kawada N.

    Am J Gastroenterol. 2011 Oct;106(10):1865-6. doi: 10.1038/ajg.2011.258. No abstract available.

    PMID:
    21979218
    [PubMed - indexed for MEDLINE]
    5.

    Editorial: Measurement of HBsAg concentration during antiviral therapy of hepatitis B: who, when, and why.

    Perrillo R.

    Am J Gastroenterol. 2011 Oct;106(10):1774-6. doi: 10.1038/ajg.2011.263.

    PMID:
    21979203
    [PubMed - indexed for MEDLINE]
    6.

    The risk of multiplying diagnostic combinations in the absence of a perfect gold standard for a fibrosis test.

    Munteanu M, Ratziu V, Poynard T.

    Am J Gastroenterol. 2011 Oct;106(10):1853; author reply 1853-4. doi: 10.1038/ajg.2011.259. No abstract available.

    PMID:
    21979207
    [PubMed - indexed for MEDLINE]
    7.

    Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C.

    Sterling RK, Wright EC, Morgan TR, Seeff LB, Hoefs JC, Di Bisceglie AM, Dienstag JL, Lok AS.

    Am J Gastroenterol. 2012 Jan;107(1):64-74. doi: 10.1038/ajg.2011.312. Epub 2011 Sep 20.

    PMID:
    21931376
    [PubMed - indexed for MEDLINE]
    8.

    Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States.

    Wan DW, Tzimas D, Smith JA, Kim S, Araujo J, David R, Lobach I, Sarpel U.

    Am J Gastroenterol. 2011 Nov;106(11):1994-2000. doi: 10.1038/ajg.2011.302. Epub 2011 Sep 13.

    PMID:
    21912436
    [PubMed - indexed for MEDLINE]
    9.

    Is the lymphoma risk reduced in viral hepatitis? A cirrhotic patient with triple malignancies.

    Doganay L, Kiziltas S, Colak Y, Gulluoglu M, Tuncer I.

    Am J Gastroenterol. 2011 Sep;106(9):1719-20; author reply 1720. doi: 10.1038/ajg.2011.214. No abstract available.

    PMID:
    21897412
    [PubMed - indexed for MEDLINE]
    10.

    Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.

    Moses J, Alkhouri N, Shannon A, Raig K, Lopez R, Danziger-Isakov L, Feldstein AE, Zein NN, Wyllie R, Carter-Kent C.

    Am J Gastroenterol. 2012 Jan;107(1):133-8. doi: 10.1038/ajg.2011.295. Epub 2011 Aug 30.

    PMID:
    21876562
    [PubMed - indexed for MEDLINE]
    11.

    Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation.

    Chapman J, Oser M, Hockemeyer J, Weitlauf J, Jones S, Cheung R.

    Am J Gastroenterol. 2011 Dec;106(12):2123-32. doi: 10.1038/ajg.2011.252. Epub 2011 Aug 9.

    PMID:
    21826113
    [PubMed - indexed for MEDLINE]
    12.

    Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.

    Fung J, Lai CL, Young J, Wong DK, Yuen J, Seto WK, Yuen MF.

    Am J Gastroenterol. 2011 Oct;106(10):1766-73. doi: 10.1038/ajg.2011.253. Epub 2011 Aug 9.

    PMID:
    21826112
    [PubMed - indexed for MEDLINE]
    13.

    Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment.

    Alric L, Bonnet D, Beynes-Rauzy O, Izopet J, Kamar N.

    Am J Gastroenterol. 2011 Aug;106(8):1562-3. doi: 10.1038/ajg.2011.158. No abstract available.

    PMID:
    21811285
    [PubMed - indexed for MEDLINE]
    14.

    A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment.

    Evon DM, Simpson K, Kixmiller S, Galanko J, Dougherty K, Golin C, Fried MW.

    Am J Gastroenterol. 2011 Oct;106(10):1777-86. doi: 10.1038/ajg.2011.219. Epub 2011 Jul 19.

    PMID:
    21769136
    [PubMed - indexed for MEDLINE]
    15.

    The IL-28B genotype predicts which slow-responding hepatitis C-infected patients will benefit from treatment extension.

    Pearlman BL, Ehleben C.

    Am J Gastroenterol. 2011 Jul;106(7):1370-1. doi: 10.1038/ajg.2011.149. No abstract available.

    PMID:
    21731027
    [PubMed - indexed for MEDLINE]
    16.

    Quality of care for gastrointestinal conditions: a primer for gastroenterologists.

    Kappelman MD, Dorn SD, Peterson E, Runge T, Allen JI.

    Am J Gastroenterol. 2011 Jul;106(7):1182-7. doi: 10.1038/ajg.2011.118. Review.

    PMID:
    21731014
    [PubMed - indexed for MEDLINE]
    17.

    Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin.

    de Rueda PM, López-Nevot MÁ, Sáenz-López P, Casado J, Martín-Casares A, Palomares P, Quiles R, Gila A, Romero-Gómez M, Pavón EJ, Muñoz JA, Carazo A, Sanz-Cameno P, Moreno-Otero R, Diago M, León J, Ruiz-Extremera A, Salmerón J.

    Am J Gastroenterol. 2011 Jul;106(7):1246-54. doi: 10.1038/ajg.2011.82. Epub 2011 Jun 14.

    PMID:
    21670772
    [PubMed - indexed for MEDLINE]
    18.

    Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model.

    Kim BK, Kim do Y, Han KH, Park JY, Kim JK, Paik YH, Lee KS, Chon CY, Ahn SH.

    Am J Gastroenterol. 2011 Sep;106(9):1654-62, 1730. doi: 10.1038/ajg.2011.160. Epub 2011 Jun 21. Erratum in: Am J Gastroenterol. 2011 Sep;106(9):1730.

    PMID:
    21691339
    [PubMed - indexed for MEDLINE]
    19.

    Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.

    Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, Peveling-Oberhag J, Radeke HH, Sarrazin C, Herrmann E, Zeuzem S, Waidmann O, Piiper A.

    Am J Gastroenterol. 2011 Sep;106(9):1663-9. doi: 10.1038/ajg.2011.161. Epub 2011 May 24.

    PMID:
    21606975
    [PubMed - indexed for MEDLINE]
    20.

    Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan.

    Lai SW, Muo CH, Liao KF, Sung FC, Chen PC.

    Am J Gastroenterol. 2011 Sep;106(9):1697-704. doi: 10.1038/ajg.2011.155. Epub 2011 May 17. Erratum in: Am J Gastroenterol. 2011 Nov;106(11):2053.

    PMID:
    21577242
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk